Prior studies demonstrate that most living kidney donors (LKDs) report no adverse psychosocial outcomes; however, changes in psychosocial functioning at the individ- 
| INTRODUCTION
Living kidney donors (LKDs) account for one-third of kidney transplantations annually in the United States.
1 LKDs are not only a critical source of transplantable organs, but they provide kidney transplant recipients (KTRs) with the most optimal short-and long-term outcome and help reduce healthcare costs associated with renal failure.
LKDs themselves do not derive any medical benefit from donation, although they may benefit psychologically from helping another.
2,3
Consequently, the transplant community is committed to ensuring the safety of donor nephrectomy and minimizing donation risks.
Surgical and medical outcomes following living donation, for instance, have been characterized and continue to be targets of ongoing investigation.
4-9
Psychosocial outcomes are described in multiple studies, which generally report that most LKDs experience no serious deleterious psychosocial consequences from donation. [10] [11] [12] [13] Many studies, however, have been cross-sectional and limited to a single center. More recent prospective studies have found that some LKDs experience considerable financial loss and health insurance problems, [14] [15] [16] [17] although the full range of psychosocial outcomes has not been explored in large, multicenter prospective studies. 18 In addition, although average or mean scores on psychosocial outcomes suggest favorable outcomes overall, changes in psychosocial functioning at the individual donor level are not routinely captured. 14 This requires examining each outcome for each individual LKD to assess whether any meaningful change has occurred over time. More refined examination of these outcomes is necessary to better inform potential LKDs about the short-and long-term effects of donation along dimensions that may be important to them and how these outcomes may change over time.
Funded by the National Institutes of Health, the Kidney Donor
Outcomes Cohort (KDOC) study is a multicenter, prospective study of LKD outcomes. We previously reported on the financial impact of living donation. 16, 18 Now, we report on 5 other psychosocial outcomes-mood, fear of kidney failure, body image, life satisfaction, and decisional stability. These outcomes were selected for study because regulations have required programs to inform potential LKDs about their possible occurrence after donation (eg, depression, body image concerns), former LKDs identified them to our study group as being of high interest to potential donors, and prior literature as well as clinical experiences of the study team suggested they were of high clinical relevance and necessitated further study. The aims of the current analysis were 2-fold: (1) to characterize the incidence of adverse psychosocial outcomes postdonation, and (2) to identify predonation characteristics or variables associated with higher risk of adverse psychosocial outcomes. Identification of predonation characteristics associated with poor psychosocial outcomes following donation may help to improve the evaluation and informed consent process for future potential LKDs. Based on prior research findings, 10 we hypothesized that a history of depression, anxiety, bipolar disorder, or substance use disorder may be associated with worse postdonation psychosocial functioning. In addition, we hypothesized that higher BMI may be associated with lower postdonation body image.
| METHODS

| Kidney Donor Outcomes Cohort (KDOC)
The KDOC study (www.kdocstudy.com) examined surgical, medi- We also recruited healthy controls (HCs) into the study if they underwent evaluation but did not donate because imaging showed an anatomical issue that would not be expected to affect medical outcomes, the recipient received a deceased donor transplant or an LDKT using a different donor, or the recipient was no longer eligible for transplantation.
Because this was an observational cohort study, participating programs used their existing policies and practices to conduct medical, surgical, and psychosocial evaluation for donor candidates.
Only LKDs who were approved for donation using local criteria and who met study inclusion criteria (≥18 years, English or Spanish language) were recruited for study participation from September 2011
to November 2013. Following written informed consent, the predonation assessment was completed and we then attempted to recruit the LKD's intended recipient into the study. 
| Psychosocial outcomes
| Mood
Ten adjectives from the Profile of Mood States (POMS; Cronbach's α = 0.83) 19 were used to assess three constructs-anxiety (tense, anxious, nervous), depression (helpless, unhappy, hopeless, worthless), and anger (angry, grouchy, resentful)-and total mood disturbance.
For each adjective, LKDs and HCs indicated how they felt in the past week (0 = not at all to 4 = extremely), with higher scores indicating more mood disturbance. A total score >10 indicates the presence of possible mood disturbance. 
| Body image
The 10-item Body Image Scale (BIS; α = 0.92) 21 was used to measure concerns about general body image issues (e.g., feeling self-conscious, dissatisfied with body) and body image in relation to donor surgery (e.g., less physically attractive, body less whole). Participants indicated how they felt in the past week (0 = not at all to 3 = very much), with higher scores representing poorer body image. A total score ≥10 indicates heightened body image concerns. 22 In additionally, LKDs were asked to rate their overall satisfaction (1 = not at all satisfied, 5 = extremely satisfied) with surgical scarring at the 6-month assessment.
| Life satisfaction
The 
| LKD clinical characteristics
We examined several clinical variables at baseline, including mood disorder and substance abuse history, BMI, physical and mental quality of life, and dispositional optimism. Mood disorder and substance abuse history as well as BMI were obtained from medical record
review. Perceived quality of life at baseline was examined using the SF-36 Health Survey, 25 which yields composite scores for physical and mental health and has been used extensively with LKDs and KTRs.
Finally, LKDs completed the Life Orientation Test-Revised (LOT-R) 26 at baseline to measure dispositional optimism, a construct found to be associated with more favorable psychosocial functioning. The LOT-R yields a total score ranging from 0 to 24, with higher scores reflecting more optimism. 
| Donation-related variables
| KTR clinical characteristics
We examined the KTR's predonation dialysis status and physical and mental quality of life (SF-36 Health Survey). 
| RESULTS
| Cohort characteristics
Characteristics of LKDs (n = 193), KTRs (n = 152), and HCs (n = 20)
are reported in Table 1 . One-hundred ninety-four LKDs (84% of eligible donors during enrollment period) were enrolled into the KDOC study. However, 1 enrolled LKD died during surgery and the kidney was not transplanted, thus the participant was removed from the current analysis. As previously reported, 16 the LKD sample characteristics are similar to those of adults who donated a kidney in the United States during the KDOC enrollment period, with the exception of more college-educated donors in the KDOC sample (P = .01).
Participation rates for KTRs and HCs were 66% and 83%, respectively.
Psychosocial assessment completion rates for LKDs were as follows: 98% (n = 189) at predonation baseline, 92% (n = 177) at 1 month, 83% (n = 161) at 6 months, 81% (n = 156) at 12 months, and 85% (n = 163) at 24 months. One-hundred eighty-two LKDs (94%) completed the predonation baseline assessment and ≥1 follow-up psychosocial assessment and 138 (72%) completed all follow-up psychosocial assessments. Those who did not complete a follow-up assessment were younger than those who completed ≥1
follow-up assessment (P = .03), but did not otherwise differ based on sex, race, education, marital status, or household income.
| Psychosocial outcomes
Psychosocial outcomes for both LKDs and HCs are summarized in Table 2 . On average, there was minimal to no mood disturbance, body image concerns, fear of kidney failure, and life dissatisfaction at all time points, suggesting no incremental changes in these constructs over time. Analytic models showed no significant differences between LKD and HC trajectories over time for total mood disturbance, body image, and life satisfaction scores (all P > .05).
In the absence of mean differences between LKDs and HCs, we assessed for change from pre-to postdonation for individual LKDs and for change over time for individual HCs. Specifically, we categorized 
| Mood
The majority of LKDs (n = 165, 91%) reported no predonation total mood disturbance (Figure 1 LKDs reported moderate to severe mood disturbance at ≥1 postdonation time point. Nearly identical patterns were seen for the small HC cohort (Figure 1 ). In multivariable analysis of LKDs, we found that younger age and predonation mood disturbance were significantly associated with higher total mood disturbance postdonation (Table 3) .
| Fear of kidney failure
The (Table 3) .
| Body image
The majority of LKDs (n = 158, 87%) reported no or minimal body (Table 3) .
Among LKDs, the most commonly expressed issues that persisted over time were being self-conscious about and dissatisfied with one's appearance and being dissatisfied with one's body generally. Other body image concerns, such as feeling less physically and sexually at- 
| Life satisfaction
The majority of LKDs (n = 166, 91%) reported moderate to high life (Table 3) .
| Decision stability
Most LKDs (n = 174, 96%) had no regret about their decision to donate at any point postdonation. Of the 8 LKDs who reported decision regret, 6 experienced feelings of regret throughout the 2-year followup period.
| DISCUSSION
With few exceptions, No mood disturbance LKD n = 165, 91% HC n = 16, 84%
Mood disturbance LKD n = 17 (9%) HC n = 3, 16%
Predonation Postdonation
No mood disturbance LKD n = 139, 84% HC n = 14, 88%
Mood disturbance LKD n = 26, 16% HC n = 2, 12%
No mood disturbance LKD n = 6, 35% HC n = 1, 33%
Mood disturbance LKD n = 11, 65% HC n = 2, 67%
No mood disturbance LKD n = 145, 80% HC n = 15, 79%
Mood disturbance LKD n = 37, 20% HC n = 4, 21% donation (https://optn.transplant.hrsa.gov/media/1200/optn_policies. pdf). However, the policy is vague, stating only that LKDs should be informed that such risks "…may be temporary or permanent" (p. 183), leaving providers uncertain about the specific nature, incidence, and duration of any psychosocial changes that should be disclosed to potential LKDs. Our data provide some guidance about the pattern and occurrence of such outcomes following donation. For instance, we found that, on average, symptoms of anxiety, depression, poor body image, and life dissatisfaction did not change significantly from pre-to postdonation and that trends in these symptoms over time for LKDs were no different than those of HCs.
The incidence of any new-onset mood disturbance (16%), fear of kidney failure (21%), body image concerns (13%), and life dissatisfaction (10%) during the 2-year postdonation period was generally low.
Indeed, these findings are consistent with the conclusions reached by others.
10-15, 24, 31-33 Dew et al, 32 for instance, concluded in their review of the literature that up to 1 in 4 LKDs may experience newonset psychological distress following donation. However, these new-onset symptoms might not be attributable to donation. Indeed, the incidence of new-onset symptoms in HCs was very similar to that of LKDs. This pattern must be replicated with a larger control sample, of course, but our preliminary findings suggest that rates of mood disturbance, body image concerns, and life dissatisfaction following donation may not be significantly higher than what can be expected in nondonors over time. Until more definitive research is conducted, we agree with the recommendation that transplant programs inform potential LKDs about possible adverse psychosocial outcomes and that these risks be integrated into living donation websites to better inform those seeking donation-related information online.
34,35
In a recent review of the prevalence and clinical significance of body image concerns in transplant recipients and living donors, Zimbrean 33 reported that body image is infrequently assessed in studies of LKDs and generally not considered problematic when it is examined. In the current study, the majority (83%) was satisfied with the surgical scarring outcome and only a small minority (13%) reported new-onset body image concerns following donation (vs 6% for HCs).
Although the incidence of new-onset body image concerns may be slightly higher for LKDs, these findings support Zimbrean's conclusion that this is not a common issue for former living donors. BMI was not a significant risk factor for body image concerns postdonation, contrary to our initial hypothesis. As programs consider more obese adults for possible kidney donation, 36,37 some have suggested that obese LKDs warrant more vigilant monitoring for adverse psychosocial outcomes. 11, 38 Clearly, more research is needed to further delineate the short-and long-term body image concerns in LKDs, particularly be- 
32,39
We did not assess whether new-onset symptoms following donation interfered with life activities or necessitated clinical intervention.
Currently, the OPTN requires the assessment of only 2 psychosocial elements postdonation-employment status and the loss of health or life insurance due to donation. However, as recommended by Kidney Disease Improving Global Outcomes, transplant programs may want to consider integrating a brief psychosocial screening into the postdonation follow-up period to facilitate early identification of emerging psychosocial symptoms in LKDs who may benefit from further assessment or intervention. 40 In addition, we fully support establishing a scientific registry for LKDs that will expand both the range of outcomes data gathered following donation as well as the assessment period (ie, beyond 2 years). 41 Such a registry will facilitate more refined examination of the incidence of adverse psychosocial outcomes and their
predictors.
There are several notable strengths and limitations of the current analysis. The study benefited from LKD participants from 6 transplant centers who were generally representative of LKDs in the United States. The majority in our study (94%) completed ≥1 follow-up psychosocial assessment, in addition to the baseline predonation assessment. Moreover, we used validated instruments to assess donation outcomes that were recommended for study by former donors. In addition,, the prospective nature of the study allowed us to examine changes in psychosocial outcomes over time, in comparison to a healthy control sample. Despite these relative strengths, certain limitations should be considered in interpreting findings. Centers participating in the study may not be representative of other programs.
More or less stringent psychosocial criteria for the selection of LKDs than those used by the KDOC sites may yield different findings than we observed in this study. Furthermore, the predonation psychosocial assessment may not be an accurate representation of symptoms for some LKDs. Although the study outcomes were assessed only after LKDs were approved for donation and participants were informed that research assessments would not be shared with the donor program, some LKDs may have responded to study questionnaires in a more socially desirable manner to avoid any possibility of being excluded from donation due to psychosocial concerns. We examined adverse outcomes over a 2-year period only, thus we are unable to comment on more positive psychosocial outcomes or on the long-term psychosocial impact of donation. Finally, although it is novel to include a healthy control group in a prospective cohort study of donation outcomes, our healthy control sample was very small due to very restrictive inclusion/ exclusion criteria, thereby limiting analytic comparisons to LKDs over time.
In conclusion, this multisite study provides a prospective analysis Moderate to high life satisfaction LKD n = 166, 91% HC n = 18, 95%
Low life satisfaction LKD n = 16, 9% HC n = 1, 5%
Predonation Postdonation
Moderate to high life satisfaction LKD n = 150, 90% HC n = 16, 89%
Low life satisfaction LKD n = 16, 10% HC n = 2, 11%
Moderate to high life satisfaction LKD n = 9, 56% HC n = 0, 0% Low life satisfaction LKD n = 7, 44% HC n = 1, 100%
Moderate to high life satisfaction LKD n = 159, 87% HC n = 16, 84%
Low life satisfaction LKD n = 23, 13% HC n = 3, 16%
can be conducted, we support maintaining the regulatory requirement to inform potential donors about possible adverse psychosocial consequences. Moreover, the development and implementation of a donor registry to capture psychosocial outcomes beyond the mandatory 2-year follow-up period in the United States will further refine our understanding of these outcomes over time.
